Overview

Magnesium Administration in Liver Transplantation and Reperfusion Injury

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the effect of intravenous magnesium infusion before reperfusion with employing some clinical parameters including blood lactate levels, because the intraoperative changes in the blood lactate levels after hepatic allograft reperfusion served as an accurate predictor of the initial graft function in living donor liver transplantation.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
The Catholic University of Korea
Treatments:
Magnesium Sulfate
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

- adult patients scheduled for elective living donor liver transplantation

Exclusion Criteria:

- pediatric patients

- re-transplantation

- renal dysfunction

- cardiovascular disease